Keros Therapeutics, Inc.
NASDAQ:KROS
11.13 (USD) • At close February 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.388 | 0.037 | 0.083 | 0.143 | 0.008 | 0 | 0 | 0 | 0 | 0.1 | 0 | 20 | 0 | 0.1 | 0 | 0 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 |
| Cost of Revenue
| 0 | 0.306 | 0.277 | 0.247 | 0.551 | 0.545 | 0.689 | 0.448 | 0.337 | 0.514 | 0.316 | 0.302 | 0.223 | 9.983 | 0.179 | 9.674 | 8.395 | 7.264 | 8.527 | 4.13 | 3.854 | 4.497 | 4.867 |
| Gross Profit
| 0.388 | -0.269 | -0.194 | -0.104 | -0.543 | -0.545 | -0.689 | -0.448 | -0.337 | -0.414 | -0.316 | 19.698 | -0.223 | -9.883 | -0.179 | -9.674 | -5.895 | -4.764 | -6.027 | -1.63 | -1.354 | -1.997 | -2.367 |
| Gross Profit Ratio
| 1 | -7.27 | -2.337 | -0.727 | -67.875 | 0 | 0 | 0 | 0 | -4.14 | 0 | 0.985 | 0 | -98.83 | 0 | 0 | -2.358 | -1.906 | -2.411 | -0.652 | -0.542 | -0.799 | -0.947 |
| Reseach & Development Expenses
| 49.225 | 40.515 | 38.258 | 37.493 | 34.14 | 32.534 | 31.091 | 24.867 | 21.039 | 23.281 | 18.078 | 18.834 | 14.832 | 9.983 | 11.495 | 9.674 | 8.395 | 7.264 | 8.527 | 4.161 | 3.854 | 4.497 | 4.867 |
| General & Administrative Expenses
| 9.82 | 9.961 | 10.308 | 9.105 | 9.148 | 8.803 | 7.778 | 7.093 | 6.937 | 7.447 | 6.048 | 6.033 | 5.365 | 5.658 | 4.274 | 3.617 | 3.553 | 3.65 | 1.977 | 1.067 | 0.972 | 0.654 | 0.491 |
| Selling & Marketing Expenses
| 0 | -0.306 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.82 | 9.655 | 10.308 | 9.105 | 9.148 | 8.803 | 7.778 | 7.093 | 6.937 | 7.447 | 6.048 | 6.033 | 5.365 | 5.658 | 4.274 | 3.617 | 3.553 | 3.65 | 1.977 | 1.067 | 0.972 | 0.654 | 0.491 |
| Other Expenses
| 0 | -0.196 | -0.437 | -10.943 | 3.84 | 3.832 | 3.065 | 2.242 | -3.705 | -3.376 | -0.059 | -0.074 | -0.137 | -0.08 | -0.065 | 0.156 | -0.086 | 0.158 | -1.558 | -0.022 | -1.22 | -0.578 | -0.503 |
| Operating Expenses
| 59.045 | 50.17 | 48.566 | 44.198 | 43.288 | 41.337 | 38.869 | 31.96 | 24.271 | 27.352 | 24.126 | 24.867 | 20.197 | 15.641 | 15.769 | 10.831 | 11.948 | 10.914 | 10.504 | 5.228 | 4.826 | 4.773 | 5.178 |
| Operating Income
| -58.657 | -50.439 | -48.483 | -46.455 | -43.28 | -41.337 | -38.869 | -31.96 | -27.976 | -30.728 | -24.126 | -4.867 | -20.197 | -15.541 | -15.769 | -13.291 | -11.948 | -10.914 | -10.504 | -2.728 | -2.326 | -2.651 | -2.858 |
| Operating Income Ratio
| -151.178 | -1,363.216 | -584.133 | -324.86 | -5,410 | 0 | 0 | 0 | 0 | -307.28 | 0 | -0.243 | 0 | -155.41 | 0 | 0 | -4.779 | -4.366 | -4.202 | -1.091 | -0.93 | -1.06 | -1.143 |
| Total Other Income Expenses Net
| 5.701 | 5.182 | 5.369 | 6.212 | 3.84 | 3.832 | 3.065 | 2.242 | 4.467 | 3.462 | -0.06 | -0.075 | -0.138 | -0.081 | -0.066 | 2.615 | -0.088 | 0.157 | -1.56 | -0.023 | -1.223 | -0.202 | -0.325 |
| Income Before Tax
| -52.956 | -45.257 | -43.114 | -40.243 | -39.44 | -37.505 | -35.804 | -29.718 | -23.509 | -27.266 | -24.186 | -4.942 | -20.335 | -15.622 | -15.835 | -10.676 | -12.036 | -10.757 | -12.064 | -2.751 | -3.549 | -2.853 | -3.183 |
| Income Before Tax Ratio
| -136.485 | -1,223.162 | -519.446 | -281.42 | -4,930 | 0 | 0 | 0 | 0 | -272.66 | 0 | -0.247 | 0 | -156.22 | 0 | 0 | -4.814 | -4.303 | -4.826 | -1.1 | -1.42 | -1.141 | -1.273 |
| Income Tax Expense
| 0 | 0 | -0.277 | 3.812 | -0.21 | 3.832 | -3.065 | 0.002 | -4.467 | -3.462 | 0.001 | 1.998 | -0.038 | -0.079 | 0.05 | 0.082 | -0.156 | 0.001 | -0.172 | 2.302 | -1.217 | 0.002 | 0.002 |
| Net Income
| -52.956 | -45.257 | -43.114 | -40.243 | -39.44 | -37.505 | -32.739 | -29.72 | -19.042 | -23.804 | -24.187 | -6.94 | -20.297 | -15.622 | -15.885 | -10.676 | -12.036 | -10.757 | -11.892 | -2.751 | -3.549 | -2.853 | -3.183 |
| Net Income Ratio
| -136.485 | -1,223.162 | -519.446 | -281.42 | -4,930 | 0 | 0 | 0 | 0 | -238.04 | 0 | -0.347 | 0 | -156.22 | 0 | 0 | -4.814 | -4.303 | -4.757 | -1.1 | -1.42 | -1.141 | -1.273 |
| EPS
| -1.47 | -1.25 | -1.46 | -1.34 | -1.33 | -1.27 | -1.15 | -1.09 | -0.75 | -0.99 | -1.01 | -0.3 | -0.87 | -0.67 | -0.68 | -0.49 | -0.6 | -0.61 | -0.65 | -0.31 | -0.4 | -0.32 | -0.36 |
| EPS Diluted
| -1.47 | -1.25 | -1.46 | -1.34 | -1.33 | -1.27 | -1.15 | -1.09 | -0.75 | -0.99 | -1.01 | -0.3 | -0.87 | -0.67 | -0.68 | -0.49 | -0.6 | -0.61 | -0.65 | -0.31 | -0.4 | -0.32 | -0.36 |
| EBITDA
| -58.657 | -50.133 | -48.206 | -39.996 | -43.07 | -41.146 | -38.869 | -29.27 | -20.197 | -30.128 | -24.072 | -4.639 | -20.197 | -15.428 | -15.769 | -10.502 | -11.913 | -10.597 | -11.91 | -0.368 | -3.491 | -2.224 | -2.813 |
| EBITDA Ratio
| -151.178 | -1,354.946 | -584.133 | -279.692 | -5,410 | 0 | 0 | 0 | 0 | -269.58 | 0 | -0.247 | 0 | -155.3 | 0 | 0 | -4.814 | -4.338 | -4.176 | -0.147 | -1.396 | -0.89 | -1.053 |